In this webinar, experts discuss new approaches to biomarker discovery and share the research avenues that elucidate the ...

A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...

The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was ...

Genialis expands its collaboration with Debiopharm, deploying Expressions to support standardized biomarker discovery and ...

In recent years, the field of oncology has increasingly acknowledged cancer as a metabolic disorder with significant ...

Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...

The Strategic Role of Biomarkers in Drug Discovery and Clinical Trials Every decision in drug development carries weight. The ...

Proteomic mass spectrometry can identify key biomarkers in IPF, aiding in diagnosis and prognosis despite the disease's ...

Ibex’s high-performance AI platform—already deployed across more than 50 health systems worldwide and used in collaboration ...

Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...

Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...